Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04240327

Marker Driven Selection of Patients for Prostate Biopsy and Management

Marker Driven Selection of Patients for Prostate Biopsy and Management: The University of Miami MDSelect Protocol

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
289 (actual)
Sponsor
University of Miami · Academic / Other
Sex
Male
Age
40 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood and urine biomarkers is more effective at detecting prostate cancer than standard of care interpretation of mpMRI with the Prostate Imaging Reporting and Data System (PIRADS).

Conditions

Timeline

Start date
2020-06-29
Primary completion
2027-06-01
Completion
2027-06-01
First posted
2020-01-27
Last updated
2025-06-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04240327. Inclusion in this directory is not an endorsement.

Marker Driven Selection of Patients for Prostate Biopsy and Management (NCT04240327) · Clinical Trials Directory